Headlines

заголовки анонсы
13.02.2026
23:29 Bioengineer.org Unveiling the Evolution of Sharp Vision: Insights from Lab-Grown Retinas

In a groundbreaking study, scientists at Johns Hopkins University have made significant strides in our understanding of retinal development and its implications for vision health. This research reveals critical interactions between vitamin A derivatives, specifically retinoic acid, and thyroid hormones during early fetal development in humans, providing new insights into how our eyes develop the […]

Скрыть анонс
23:16 Biopharmadive.com Vertex’s CRISPR therapy rebounds in latest earnings

Sales of Casgevy, a gene-edited treatment developed with CRISPR Therapeutics, more than tripled compared to the third quarter, a performance analysts saw as a bright spot in Vertex's report.

Скрыть анонс
22:39 Phys.org How did humans develop sharp vision? Lab-grown retinas show likely answer

Humans develop sharp vision during early fetal development thanks to an interplay between a vitamin A derivative and thyroid hormones in the retina, Johns Hopkins University scientists have found. The findings could upend decades of conventional understanding of how the eye grows light-sensing cells and could inform new research into treatments for macular degeneration, glaucoma, and other age-related vision disorders. Details of the study, which used lab-grown retinal tissue, are published today in Proceedings of the National Academy of Sciences.

Скрыть анонс
22:38 FightAging.org The ARMOR Study of Fecal Microbiota Transplantation to Treat Aging

The composition of the gut microbiome, the relative sizes of the various microbial populations, changes with age in ways that promote chronic inflammation and dysfunction throughout the body. The production of beneficial metabolites decreases, while microbes capable of provoking a constant inflammatory reaction increase in number. Studies of fecal microbiota transplantation have demonstrated that the unfavorable composition of the gut microbiome in old animals can be rejuvenated via the introduction of donor material from young animals. One treatment produces lasting rejuvenation, though presumably the processes of aging will slowly degrade the gut microbiome over time, just as they did before. Health is improved and life span increased. Fecal microbiota transplantation sees enough use in medicine for researchers and clinicians to broadly understand the safety profile […]

Скрыть анонс
21:37 Power Engineering Listening, integrating and scaling: How SENS is positioning for growth in critical power

Olen Scott, Chief Commercial Officer at Stored Energy Systems (SENS), discusses reliability challenges in data centers and why factory-integrated solutions are superior to multi-vendor approaches.

Скрыть анонс
21:22 MedicalXpress.com Combating leukemia by stopping stem cells from turning cancerous

Acute myeloid leukemia (AML) is an aggressive form of blood cancer. It affects people of all ages but is most common in those over 65. Around 150 people are diagnosed with the disease each year in Norway. Men are affected slightly more often than women. Fewer than 5 in 100 patients over the age of 65 survive.

Скрыть анонс
19:28 MedicalXpress.com Cell and gene therapy across 35 years—a bibliometric analysis of global advances

Cell and gene therapies, or CGT, have come a long way since they were first introduced. In the last few decades, both cell therapy—the transplantation of living cells—and gene therapy—the use of genetic material to modify cell functions—have been increasingly incorporated into clinical practice.

Скрыть анонс
19:15 MedicalXpress.com Human stem cell lines offer new resource to help study HIV progression

King's College London researchers have created a unique collection of human stem cell models that could help to uncover why HIV leads to different outcomes in different people. The research was carried out by Dr. Nathalia Almedia, postdoctoral researcher, and Sam Acors, former Ph.D. student, who are co-lead authors of the paper published in Stem Cell Reports.

Скрыть анонс
18:40 Yahoo Finance Oracle Wins CMS Cloud Contract To Power Medicare, Medicaid Modernization

Скрыть анонс
15:26 SciTechDaily.com AI-Designed Obesity Drug Delivers Over 31% Weight Loss in Preclinical Tests

New approaches to obesity treatment are emerging as scientists target underexplored metabolic pathways with the help of artificial intelligence. Demand for better obesity medicines is rising quickly, with the market forecast to reach USD 60.53 billion by 2030. Even so, widely used treatments such as GLP-1 receptor agonists (GLP-1RAs) still come with well-known tradeoffs. Patients [...]

Скрыть анонс
13:10 Benzinga.com Pay $1 Million A Year To 'Not Die'? Silicon Valley's Anti-Aging Billionaire Opens Elite Longevity Program With Just Three Spots

Bryan Johnson unveils a $1 million-a-year "Immortals" health program, offering ultra-elite access to his extreme anti-aging protocol. Importance Rank:  1 read more

Скрыть анонс
12:02 Labiotech.eu Using AI to crack undruggable drug targets

Today, we welcome Avital Sharir-Ivry, Co-Founder and Chief Scientific Officer of ProPhet, an Israeli startup launched from the AION Labs venture studio. The post Using AI to crack undruggable drug targets appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Скрыть анонс
11:25 Arxiv.org CS Toward Reliable Tea Leaf Disease Diagnosis Using Deep Learning Model: Enhancing Robustness With Explainable AI and Adversarial Training

arXiv:2602.11239v1 Announce Type: new Abstract: Tea is a valuable asset for the economy of Bangladesh. So, tea cultivation plays an important role to boost the economy. These valuable plants are vulnerable to various kinds of leaf infections which may cause less production and low quality. It is not so easy to detect these diseases manually. It may take time and there could be some errors in the detection.Therefore, the purpose of the study is to develop an automated deep learning model for tea leaf disease classification based on the teaLeafBD dataset so that anyone can detect the diseases more easily and efficiently. There are 5,278 high-resolution images in this dataset. The images are classified into seven categories. Six of them represents various diseases and the rest one represents healthy leaves. The proposed pipeline contains data preprocessing, data splitting, adversarial training, augmentation, model training, evaluation, and comprehension made possible with Explainable AI

Скрыть анонс
11:25 Arxiv.org CS AI-Driven Clinical Decision Support System for Enhanced Diabetes Diagnosis and Management

arXiv:2602.11237v1 Announce Type: new Abstract: Identifying type 2 diabetes mellitus can be challenging, particularly for primary care physicians. Clinical decision support systems incorporating artificial intelligence (AI-CDSS) can assist medical professionals in diagnosing type 2 diabetes with high accuracy. This study aimed to assess an AI-CDSS specifically developed for the diagnosis of type 2 diabetes by employing a hybrid approach that integrates expert-driven insights with machine learning techniques. The AI-CDSS was developed (training dataset: n = 650) and tested (test dataset: n = 648) using a dataset of 1298 patients with and without type 2 diabetes. To generate predictions, the algorithm utilized key features such as body mass index, plasma fasting glucose, and hemoglobin A1C. Furthermore, a clinical pilot study involving 105 patients was conducted to assess the diagnostic accuracy of the system in comparison to non-endocrinology specialists. The AI-CDSS showed a high

Скрыть анонс
10:47 BioTecnika.org World’s First Breath-Delivered Gene Therapy Sparks Breakthrough in Lung Cancer

World’s First Breath-Delivered Gene Therapy Sparks Breakthrough in Lung Cancer Imagine fighting lung cancer not with another drip stand or a handful of pills but with a breath. In what could mark a major shift in cancer treatment, researchers are testing the first-ever inhalable gene therapy for lung cancer, and early results suggest it may […] The post World’s First Breath-Delivered Gene Therapy Sparks Breakthrough in Lung Cancer appeared first on BioTecNika.

Скрыть анонс
09:33 Yahoo.com Business CareDx Expands “Transplant Plus” Into Cell Therapy, Showcases AlloHeme AML/MDS Relapse Data

Скрыть анонс
08:24 Yahoo Finance Is Oscar Health (OSCR) One of the Under-the-Radar AI Stocks to Buy?

Скрыть анонс
07:06 Bioengineer.org 35 Years of Progress in Cell and Gene Therapy

In the ever-evolving landscape of medical science, few fields have witnessed as profound a transformation in recent decades as cell and gene therapy (CGT). These groundbreaking modalities, which include the transplantation of living cells and the genetic modification of cellular functions, are not merely concepts of the future—they are actively reshaping clinical practices worldwide. Researchers […]

Скрыть анонс
05:01 Bioengineer.org Kyung Hee University Innovates AI in Wireless Health

In a groundbreaking study emerging from Kyung Hee University, researchers have made significant strides in the application of artificial intelligence in the fields of wireless communications and healthcare. The team, comprising C.S. Hong, E.N. Huh, and H. Shin, has unveiled innovative methodologies that leverage AI to enhance the efficiency of communication systems while also revolutionizing […]

Скрыть анонс
02:55 SciTechDaily.com New Stem Cell Treatment Sparks Hope for Parkinson’s Disease

A pioneering clinical trial is exploring whether lab-engineered stem cells can restore dopamine production in people with Parkinson’s disease. In Parkinson’s disease, the problem starts deep in the brain, where a small group of cells gradually fails. The condition is progressive and affects more than one million people in the United States, with roughly 90,000 [...]

Скрыть анонс
02:51 Techcrunch.Com For $1 million, you can pay Bryan Johnson (or BryanAI?) to teach you how to live longer

The longevity-obsessed investor Bryan Johnson is charging $1 million to sign up for his "Immortals" program.

Скрыть анонс
00:50 Benzinga.com CRISPR Therapeutics Earnings Report: Q4 Overview

Importance Rank:  1 read more

Скрыть анонс
12.02.2026
22:16 TechSpot.com Minecraft clone Allumeria was kicked off Steam after an AI bot filed a copyright claim

Allumeria is a voxel-based sandbox game centered on exploration, boss fights, and dungeon raids. Although it is expected to enter early access soon, the indie title nearly disappeared from Steam due to what appears to be an overzealous AI bot.Read Entire Article

Скрыть анонс
21:25 Google news Health The business of not ageing: Why people are spending $1,300 on longevity treatments - BBC

The business of not ageing: Why people are spending $1,300 on longevity treatments  BBCThe longevity paradox  Fast CompanyThe Ultimate ROI: Why Longevity is the New Executive Currency  cbn.com.cy

Скрыть анонс
21:25 Google news Sci/Tech The business of not ageing: Why people are spending $1,300 on longevity treatments - BBC

The business of not ageing: Why people are spending $1,300 on longevity treatments  BBCThe longevity paradox  Fast CompanyThe Ultimate ROI: Why Longevity is the New Executive Currency  cbn.com.cy

Скрыть анонс
20:05 News-Medical.Net Groundbreaking methods identify aggressive prostate cancer

The research lays a foundation for the possibility that aggressive prostate cancer can probably be detected through a few drops of semen or blood in the long term.

Скрыть анонс
19:31 Yahoo Finance Lantern Pharma (LTRN) Advances Oncology AI and Gains Orphan Drug Recognition

Скрыть анонс
19:20 InsiderMonkey.com Lantern Pharma (LTRN) Advances Oncology AI and Gains Orphan Drug Recognition

Lantern Pharma, Inc. (NASDAQ:LTRN) is one of the best AI penny stocks to buy right now. On January 20, the FDA granted Lantern Pharma, Inc.’s (NASDAQ:LTRN) LP-284 an Orphan Drug Designation (ODD). LP-284 is an investigational small-molecule therapy for treating soft tissue sarcomas. According to Lantern Pharma, the ODD designation applies in the United States […]

Скрыть анонс
18:08 NewScientist.Com Gene editing that spreads within the body could cure more diseases

The idea of self-amplifying gene editing is to get cells to pass on packages of CRISPR machinery to their neighbours, boosting the effect

Скрыть анонс
18:00 SciTechDaily.com New Treatment May Free Kidney Transplant Recipients From Lifelong Daily Medications

A monthly infusion may one day replace daily immunosuppressant pills for kidney transplant patients. A kidney transplant can be life-changing, but it usually comes with a lifelong tradeoff: daily immunosuppressant pills that keep the immune system from attacking the donated organ. A new study suggests there may be another path in the future, one that [...]

Скрыть анонс
17:58 MedicalXpress.com Researchers expose safety gaps in AI tools for health care

A new international study suggests most clinical artificial intelligence (AI) tools are not yet ready for safe, equitable use at the bedside. In the scoping review published in Medical Research Archives, researchers including CUNY SPH Assistant Professor Karmen Williams and MS alum Ilse Siguachi examined 390 clinical AI and machine learning models published between March 2020 and December 2021 to see whether developers planned for model updating, followed best-practice development standards, and reported who was included in their data.

Скрыть анонс
16:19 News-Medical.Net AI predicts walking recovery after hip replacement surgery

Artificial intelligence can help to predict how well patients with hip osteoarthritis will be able to walk again after an operation.

Скрыть анонс
15:11 Endpts.com Leash Bio warns of 'cheating' AI models on drug-protein predictions

A small crew of scientists in Utah is warning of a thorny problem for the AI bio field. Leash Bio CEO Ian Quigley told Endpoints News he believes many of today's cutting-edge AI models are ...

Скрыть анонс
14:34 News-Medical.Net SLAMF6 discovery offers hope for non-responding cancer patients

Cancer researchers working on immunotherapies have made a big discovery: SLAMF6, a molecule on the surface of immune cells that prevents T cells from effectively attacking tumors – and, in mice, they've found a way to neutralize it.

Скрыть анонс
14:21 FightAging.org Reviewing mTOR Inhibition as a Mechanism to Slow Aging

Rapamycin is the most well studied of the mTOR inhibitors. It produces immunosuppression at high doses, and has been used in this context in the clinic for more than twenty years. At lower doses it mimics aspects of the beneficial metabolic response to calorie restriction, om particular an increased operation of the cellular maintenance processes of autophagy. In animal studies this has been demonstrated to slow aging and extend healthy life. Human clinical trial data for this lower dose anti-aging usage remains relatively sparse, unfortunately, but the results that do exist are interesting. Rapamycin is one of the most intensively studied compounds with potential effects on longevity. Available experimental data indicate that inhibition of the mTOR pathway and activation of autophagy lead to improved cellular […]

Скрыть анонс
14:09 Arxiv.org CS A Robust Optimization Approach for Regenerator Placement in Fault-Tolerant Networks Under Discrete Cost Uncertainty

arXiv:2602.11058v1 Announce Type: new Abstract: We focus on robust, survivable communication networks, where network links and nodes are affected by an uncertainty set. In this sense, any network links might fail. Besides, a signal can only travel a maximum distance before its quality falls below a certain threshold, necessitating its regeneration by regenerators installed at network nodes. In addition, the price of installing and maintaining regenerators belongs to a discrete uncertainty set. Robust optimization seeks a solution with guaranteed performance against all scenarios modeled in an uncertainty set. Thus, the problem is to find a subset of nodes with minimum cost for the placement of the regenerator, ensuring that all nodes can communicate even if a subset of network links fails. To solve the problem optimally, we propose two solution approaches, including one flow-based and one cut-based integer programming formulation, as well as their iterative exact method. Our

Скрыть анонс
14:09 Arxiv.org CS AI-PACE: A Framework for Integrating AI into Medical Education

arXiv:2602.10527v1 Announce Type: new Abstract: The integration of artificial intelligence (AI) into healthcare is accelerating, yet medical education has not kept pace with these technological advancements. This paper synthesizes current knowledge on AI in medical education through a comprehensive analysis of the literature, identifying key competencies, curricular approaches, and implementation strategies. The aim is highlighting the critical need for structured AI education across the medical learning continuum and offer a framework for curriculum development. The findings presented suggest that effective AI education requires longitudinal integration throughout medical training, interdisciplinary collaboration, and balanced attention to both technical fundamentals and clinical applications. This paper serves as a foundation for medical educators seeking to prepare future physicians for an AI-enhanced healthcare environment.

Скрыть анонс
14:09 Arxiv.org CS Comp2Comp: Open-Source Software with FDA-Cleared Artificial Intelligence Algorithms for Computed Tomography Image Analysis

arXiv:2602.10364v1 Announce Type: new Abstract: Artificial intelligence allows automatic extraction of imaging biomarkers from already-acquired radiologic images. This paradigm of opportunistic imaging adds value to medical imaging without additional imaging costs or patient radiation exposure. However, many open-source image analysis solutions lack rigorous validation while commercial solutions lack transparency, leading to unexpected failures when deployed. Here, we report development and validation for two of the first fully open-sourced, FDA-510(k)-cleared deep learning pipelines to mitigate both challenges: Abdominal Aortic Quantification (AAQ) and Bone Mineral Density (BMD) estimation are both offered within the Comp2Comp package for opportunistic analysis of computed tomography scans. AAQ segments the abdominal aorta to assess aneurysm size; BMD segments vertebral bodies to estimate trabecular bone density and osteoporosis risk. AAQ-derived maximal aortic diameters were

Скрыть анонс
12:17 Benzinga.com Google DeepMind CEO Demis Hassabis Says AI Will Usher In 'New Golden Era Of Discovery' Within 15 Years, Transforming Medicine, Energy, Space

Google DeepMind CEO predicts AI's potential to revolutionize medicine & science in next decade, while warning of potential job impact. Importance Rank:  1 read more

Скрыть анонс
11:23 Medscape.Com Canadians Who Turn to AI for Health Information Risk Harm

People who follow health advice from artificial intelligence platforms and search results are five times more likely to experience harm than those who do not.

Скрыть анонс
10:07 Medscape.Com Heart Device Rivals Transplant Survival in Young HF Patients

Implantation of a left ventricular assist device offers survival outcomes similar to heart transplantation in young patients with advanced heart failure, a study finds.

Скрыть анонс
05:20 Endpts.com Hinge Health is looking to build AI tools for mental health support

Hinge Health is building an AI-powered mental health platform alongside its virtual physical therapy services, according to job listings Endpoints News viewed. Among the listings, the company is looking to hire a senior engineering manager ...

Скрыть анонс
01:10 Gizmodo.com Jar Jar Binks’ New ‘Star Wars’ Comic Finally Does Something About His Clone Wars Complicity

How do you answer Jar Jar paving the way for the rise of the Galactic Empire? You let him start a little rebellion, as a treat.

Скрыть анонс
11.02.2026
23:12 Google news Health Bijou Phillips Hospitalized, In Desperate Need of Kidney Transplant - TMZ

Bijou Phillips Hospitalized, In Desperate Need of Kidney Transplant  TMZBijou Phillips Hospitalized in Los Angeles Amid Desperate Plea for New Kidney  The Hollywood ReporterBijou Phillips Is Urgently Seeking Kidney Donor While Hospitalized: ‘Time Is of the Essence’  Rolling StoneBijou Phillips in hospital and in need of a kidney transplant, representative says  The IndependentBijou Phillips hospitalized and desperately seeking kidney donor after first transplant failed  Daily Mail

Скрыть анонс
23:12 Google news Sci/Tech Bijou Phillips Hospitalized, In Desperate Need of Kidney Transplant - TMZ

Bijou Phillips Hospitalized, In Desperate Need of Kidney Transplant  TMZBijou Phillips Hospitalized in Los Angeles Amid Desperate Plea for New Kidney  The Hollywood ReporterBijou Phillips Is Urgently Seeking Kidney Donor While Hospitalized: ‘Time Is of the Essence’  Rolling StoneBijou Phillips in hospital and in need of a kidney transplant, representative says  The IndependentBijou Phillips hospitalized and desperately seeking kidney donor after first transplant failed  Daily Mail

Скрыть анонс
22:30 CalClimateAg.org Community and Connection at the Burroughs Regenerative Tree Nut Field Day

Last week, CalCAN staff attended a regenerative tree nut field day at Burroughs Family Farms in Denair, CA. Ward and Rosie Burroughs along with their five grown children grow organic almonds, olive oil, milk, cheese, and pasture-raised eggs and meats. The post Community and Connection at the Burroughs Regenerative Tree Nut Field Day appeared first on CalCAN - California Climate & Agriculture Network.

Скрыть анонс
22:20 MedicalXpress.com Studies test whether gene-editing can fix high cholesterol. For now, take your medicine

Scientists are testing an entirely new way to fight heart disease: a gene-editing treatment that might offer a one-time fix for high cholesterol.

Скрыть анонс
22:20 FightAging.org mTOR Inhibitors Reduce DNA Damage and Consequent Cellular Senescence in Immune Cells

Rapamycin and other mTOR inhibitors mimic some of the mechanisms making up the response to calorie restriction. Their most interesting effect is to increase the operation of autophagy in cells. Autophagy is a collection of processes responsible for recycling damaged or unwanted proteins and structures in the cell. A large proportion of the approaches shown to modestly slow aging in yeast, worms, flies, and mice are characterized by increased or more efficient autophagy; it is a universal response to stress of any sort placed upon a cell. Too much autophagy can be a bad thing, but a modest increase improves health in the context of the dysfunctional, damaged environment of aged tissues. Another feature of mTOR inhibitors, and the age-slowing interventions that are characterized by […]

Скрыть анонс
21:58 Yahoo Science Studies test whether gene-editing can fix high cholesterol. For now, take your medicine

The latest news and headlines from Yahoo! News. Get breaking news stories and in-depth coverage with videos and photos.

Скрыть анонс
21:08 InsiderMonkey.com Is Oscar Health (OSCR) One of the Under-the-Radar AI Stocks to Buy?

Oscar Health Inc. (NYSE:OSCR) is one of theunder-the-radar AI stocks to buy. On January 9, UBS upgraded Oscar Health to Neutral from Sell and raised the price target to $17 from $12. The firm believes that Oscar’s exchange enrollment is holding up better than feared despite the expiration of enhanced subsidies. UBS suggests the shares […]

Скрыть анонс
21:02 MedicalXpress.com Human mesenchymal stem cells show promise in treating neonatal brain damage, paving way for stem cell trials

Every year, around 15 million babies worldwide are born before 37 weeks of gestation. Being born preterm can disrupt development, and earlier births increase the risk of life-changing health outcomes. There are currently no treatment options for brain injury that occurs because of preterm birth, but progress has been made thanks to the PREMSTEM project.

Скрыть анонс
19:28 FarmAndDairy.com How active hutch ventilation improves calf health and herd longevity

Discover how active calf hutch ventilation reduces heat stress and bacteria while increasing the likelihood of calves staying in the herd long-term. The post How active hutch ventilation improves calf health and herd longevity appeared first on Farm and Dairy.

Скрыть анонс
19:06 SiliconRepublic.com How the careful use of AI can benefit mental health services

UL’s Prof Pepijn van de Ven discusses his research, which involves using simple AI models to benefit mental health interventions. Read more: How the careful use of AI can benefit mental health services

Скрыть анонс
19:02 NewScientist.Com First ever inhalable gene therapy for cancer gets fast-tracked by FDA

A gene therapy that patients breathe in has been found to shrink lung tumours by inserting immune-boosting genes into surrounding cells

Скрыть анонс
17:28 TomsHardware.com Adding AI to sinus surgery system saw malfunctions rocket from eight to 100 incidents, according to new investigation — skull-puncturing errors are the stuff of nightmares

The introduction of AI to the operating theater doesn’t always work out as optimists, or the FDA, might expect.

Скрыть анонс
16:42 Bioengineer.org Lab-Grown Human Spinal Cord Organoids Show Promise in Paralysis Treatment

In a groundbreaking advancement poised to redefine treatment approaches for devastating spinal cord injuries, researchers at Northwestern University have engineered the most sophisticated human spinal cord organoid model to date. These miniature, lab-grown tissues replicate the complex cellular environment of the human spinal cord, enabling unprecedented insights into injury mechanisms and regenerative therapies. By deploying […]

Скрыть анонс
15:30 Zdrav.expert Международный конгресс по anti-age и эстетической медицине — ENTERESTET 2026

TAdviser - портал выбора технологий и поставщиков

Скрыть анонс
13:54 VulcanPost.com Yet another lab-grown protein firm flops in Singapore, 3rd in three years

Singapore’s appetite for alternative meat seems to be waning, with yet another lab-grown meat company biting the dust. Cultivated meat company Avant Proteins is shutting down its Singapore operations, reported a notice on Singapore’s Government Gazette. The seafood cell research company declared on Jan 30 that it was voluntarily winding up its business here due […]

Скрыть анонс
13:28 Google news Health Fitbit’s AI health coach is now available on your iPhone - The Verge

Fitbit’s AI health coach is now available on your iPhone  The VergeFitbit Coach preview expanding internationally, coming to iOS  9to5GoogleGoogle Brings Fitbit AI Health Coach to iPhone as Apple Pulls Back on iOS 27 Health Plans  MacRumorsThe great Fitbit expansion is finally here as it reaches more countries and devices  PhoneArenaFitbit's Crazy New Experience Just Landed for iOS Users  Droid Life

Скрыть анонс
13:28 Google news Sci/Tech Fitbit’s AI health coach is now available on your iPhone - The Verge

Fitbit’s AI health coach is now available on your iPhone  The VergeFitbit Coach preview expanding internationally, coming to iOS  9to5GoogleGoogle Brings Fitbit AI Health Coach to iPhone as Apple Pulls Back on iOS 27 Health Plans  MacRumorsThe great Fitbit expansion is finally here as it reaches more countries and devices  PhoneArenaFitbit's Crazy New Experience Just Landed for iOS Users  Droid Life

Скрыть анонс
13:00 MedicalXpress.com 'Dancing molecules' paralysis treatment heals lab-grown human spinal cord organoids

Northwestern University scientists have developed the most advanced organoid model for human spinal cord injury to date. In a new study, the research team used lab-grown human spinal cord organoids—miniature organs derived from stem cells—to model different types of spinal cord injuries and test a promising new regenerative therapy. The study is published in the journal Nature Biomedical Engineering.

Скрыть анонс
10:10 TechMeme.com Ant, which elevated its health unit to the same level as Alipay and its lending businesses, is betting on AI-powered healthcare to fuel its next phase of growth (Bloomberg)

Bloomberg: Ant, which elevated its health unit to the same level as Alipay and its lending businesses, is betting on AI-powered healthcare to fuel its next phase of growth  —  Roughly five years ago, Ant Group Co. reined in its ambitions after a derailed initial public offering.

Скрыть анонс
09:31 Arxiv.org CS An open-source implementation of a closed-loop electrocorticographic Brain-Computer Interface using Micromed, FieldTrip, and PsychoPy

arXiv:2602.09735v1 Announce Type: new Abstract: We present an open-source implementation of a closed-loop Brain-Computer Interface (BCI) system based on electrocorticographic (ECoG) recordings. Our setup integrates FieldTrip for interfacing with a Micromed acquisition system and PsychoPy for implementing experiments. We open-source three custom Python libraries (psychopylib, pymarkerlib, and pyfieldtriplib) each covering different aspects of a closed-loop BCI interface: designing interactive experiments, sending event information, and real-time signal processing. Our modules facilitate the design and operation of a transparent BCI system, promoting customization and flexibility in BCI research, and lowering the barrier for researchers to translate advances in ECoG decoding into BCI applications.

Скрыть анонс
09:08 South China Morning Post Capital injection: China backs AI drug makers in self-reliance drive

China’s state-backed investors are stepping up funding for artificial intelligence-driven drug developers as Beijing pushes for technological self-reliance, with at least one company already advancing an AI-designed therapy into late-stage clinical trials. Hangzhou-based METiS TechBio, founded in 2020, raised 400 million yuan in Series D financing in August last year, led by the Beijing Medical and Health Industry Investment Fund and the Daxing Industrial Investment Fund – both government-linked...

Скрыть анонс
06:08 TechMeme.com Isomorphic Labs, a Google DeepMind spinoff, unveils IsoDDE, a drug design system it says surpasses AlphaFold 3 in predicting biomolecular structures (Isomorphic Labs)

Isomorphic Labs: Isomorphic Labs, a Google DeepMind spinoff, unveils IsoDDE, a drug design system it says surpasses AlphaFold 3 in predicting biomolecular structures  —  Today, we are excited to share an update on our progress towards a new frontier of drug design.  We have unlocked a new paradigm …

Скрыть анонс
05:06 SeekingAlpha.com Hinge Health outlines 25% revenue growth target for 2026 while expanding AI-driven care

© seekingalpha.com. Use of this feed is limited to personal, non-commercial use and is governed by Seeking Alpha's Terms of Use (https://about.seekingalpha.com/terms). Publishing this feed for public or commercial use and/or misrepresentation by a third party is prohibited.

Скрыть анонс
04:50 Phys.org Researchers discover L1td1 maintains stem cell pluripotency by degrading totipotency-associated RNAs

A new study has found that L1td1, a protein evolutionarily co-opted from the Long interspersed nuclear element 1 (LINE1) retrotransposon, functions as a critical "gatekeeper" restricting pluripotent stem cells (PSCs) from reverting to a totipotent state. The research demonstrates that loss of L1td1 triggers the reactivation of totipotency-associated genes and endogenous retroviruses (ERVs), prompting cells to spontaneously regress to a totipotent-like (or 2-cell-like) state that mirrors the earliest stages of embryogenesis. Notably, the study identifies L1td1 as a key post-transcriptional regulator that suppresses endogenous viral elements to sustain pluripotency.

Скрыть анонс
04:36 Bioengineer.org Primed Stem Cells Combat Schistosomiasis Fibrosis via Itgb2-Rac1

In a groundbreaking study poised to revolutionize the therapeutic strategies for schistosomiasis-associated fibrosis, researchers have unveiled a novel mechanism by which primed mesenchymal stem cells (MSCs) orchestrate the attenuation of fibrotic progression. This discovery, detailed in a recent publication in Cell Death Discovery, elucidates how MSCs, once primed, potentiate macrophage subset switching and enhance efferocytosis […]

Скрыть анонс
03:44 MedicalXpress.com Robotic medical crash cart eases workload for health care teams

Health care workers have an intense workload and often experience mental distress during resuscitation and other critical care procedures. Although researchers have studied whether robots can support human teams in other high-stakes, high-risk settings such as disaster response and military operations, the role of robots in emergency medicine has not been explored.

Скрыть анонс
02:17 Medscape.Com FDA Clears AI Program for Lung Cancer Screening

Eyonis LCS aids in both detecting and characterizing nodules, distinguishing it from its many competitors.

Скрыть анонс
01:52 Bioengineer.org From Fixing Aging to Preserving Harmony: Scientists Rethink Longevity Goals for 2026

Berlin, April 2026 — The field of longevity science is undergoing a transformative evolution. Traditionally fixated on identifying singular “anti-aging” solutions, researchers are now beginning to embrace a far more intricate conceptual framework: aging may no longer be viewed as a mere accumulation of damage or defects, but rather as a progressive decline in the […]

Скрыть анонс
01:15 Bioengineer.org AI Decoding Chemical Principles to Speed Up Innovation in Drug and Material Development

In the relentless quest to revolutionize materials science and pharmaceutical development, one of the towering challenges lies in predicting the most stable molecular structures with utmost precision. The stability of molecules directly impacts the performance and efficacy of a wide array of products—from smartphone batteries that endure longer charge cycles to innovative drugs capable of […]

Скрыть анонс
00:55 TheVerge.com Fitbit expands access to its AI health coach

Google announced on Tuesday that the public preview of Fitbit's AI personal health coach is rolling out to iOS users in the U.S. as well as both iOS and Android users in the UK, Canada, Australia, New Zealand, and Singapore. It initially launched in October, when it was only available in the U.S. on Android devices. To try out the feature, users need to have an active Fitbit Premium subscription and use a Google account to sign into the Fitbit app. They also need to use one of the 14 currently-supported devices, which include Fitbit's wearables, as well as the Pixel Watch. According to Fitbit, the AI health coach will be rolling out "over … Read the full story at The Verge.

Скрыть анонс
00:40 BrownFieldAgNews.com Wisconsin Senate to vote on lab-grown protein bill

The Wisconsin State Senate will vote on Wednesday on legislation that would regulate lab-grown animal cells. Assembly Bill 554 would require the label “lab grown meat” for any food product containing cultured animal cells or animal tissue derived from cultured cells.  Jason Mugnaini with Wisconsin Farm Bureau says the state’s ag coalition strongly supports this […] The post Wisconsin Senate to vote on lab-grown protein bill appeared first on Brownfield Ag News.

Скрыть анонс
00:37 MedicalXpress.com 3D-printed brain models could improve medical research and training

University of Missouri researchers are developing new ways to better simulate the complex nature of human brain tissue. For years, scientists have worked to uncover how the brain responds to mechanical forces and electromagnetic waves. Computer models offer useful simulations, but they don't fully capture what goes on inside a living brain. Now, the team from Mizzou's College of Engineering is working to close that gap by developing 3D-printed models of an artificial human brain.

Скрыть анонс
10.02.2026
23:33 Endpts.com Isomorphic claims major advance with new AI drug design engine

Nearly two years ago, Isomorphic Labs dropped AlphaFold 3, the latest generation of its Nobel Prize-winning, structure-predicting AI model. Now the company claims it has another major advance on its hands. While ...

Скрыть анонс
23:33 MedicalXpress.com No increase seen in neovascular AMD risk after cataract surgery

The risk for neovascular age-related macular degeneration (nAMD) seems not to be increased following cataract surgery, according to a research letter published online Feb. 5 in JAMA Ophthalmology.

Скрыть анонс
22:46 AgFunderNews.com Whole Foods widens the road to regenerative certification with SCI standard

The Soil Climate Initiative is the fifth regenerative agriculture certification to land on the shelves of Whole Foods. The post Whole Foods widens the road to regenerative certification with SCI standard appeared first on AgFunderNews.

Скрыть анонс
22:42 FightAging.org A Reinvigorated Alcor and Growth in Cryonics

Cryonics refers to the low-temperature storage of the body (or at least the brain) at death to offer the chance that a more technologically capable future can restore that individual to life. It is an unknown chance, possibly a small and unknown chance, but cryonics is certainly a better option that the other end of life alternatives facing someone who is going to age to death before rejuvenation biotechnology and the medical control of aging becomes a reality. Cryonics remains a very good idea that should be far more widely used, significantly supported, and undergoing aggressive technological development to improve capabilities. But it is very far from being widely used and suffers from the same situation that afflicted the aging research community thirty years ago: […]

Скрыть анонс
21:27 SeekingAlpha.com Oscar Health expects $18.7B–$19B revenue in 2026 with 61% growth driven by record membership and AI efficiencies

Скрыть анонс
19:38 Biopharmadive.com FDA rejects Regenxbio treatment in another blow to gene therapy

The decision comes two weeks after the agency halted testing due to safety concerns and represents the latest regulatory setback for a gene therapy maker.

Скрыть анонс
19:25 Bioengineer.org Insilico Medicine and CMS Forge Multiple Collaborations to Accelerate AI-Driven R&D in CNS and Autoimmune Disorders

In a groundbreaking announcement set to redefine the future of pharmaceutical innovation, Insilico Medicine and China Medical System Holdings Limited (CMS) have embarked on an ambitious partnership to harness the power of artificial intelligence in drug discovery and development. This collaboration represents a significant leap forward in the integration of AI-driven technologies with traditional pharmaceutical […]

Скрыть анонс
18:44 MedicalXpress.com New artificial intelligence tool diagnoses masked hypertension

About 10% of people with hypertension have normal blood pressure readings at the doctor's office. Now researchers at the University of Arkansas have developed an artificial-intelligence diagnostic tool to detect this condition, known as masked hypertension. The work, led by associate professor of chemical engineering William J. Richardson, could help more people get treatment for hypertension, a condition that kills 10 million people around the world each year.

Скрыть анонс
17:56 Yahoo Finance Eli Lilly Is Partnering with Gene-Editing Start-up Seamless Therapeutics. Here's What Investors Need to Know.

Скрыть анонс
17:55 BrownFieldAgNews.com South Dakota governor rejects lab-grown meat ban, calls for 5-Year study

South Dakota Governor Larry Rhoden has vetoed a bill that would ban cell-cultured protein in the state. House Bill 1077 would make certain kinds of food, like lab-grown protein, illegal to sell in South Dakota by labeling them adulterated food. In a letter to state lawmakers, Rhoden said the bill imposes a permanent ban on lawful, […] The post South Dakota governor rejects lab-grown meat ban, calls for 5-Year study appeared first on Brownfield Ag News.

Скрыть анонс
17:52 BioTecnika.org Drug Discovery Meets AI as Takeda Unveils a $1.7 Billion High-Stakes Partnership

Drug Discovery Meets AI as Takeda Unveils a $1.7 Billion High-Stakes Partnership Drug Discovery has always been a race against time, with years of trial and error standing between a Scientific innovation and a drug that actually reaches patients worldwide. That reality is beginning to shift, not by replacing Researchers, but by equipping them with […] The post Drug Discovery Meets AI as Takeda Unveils a $1.7 Billion High-Stakes Partnership appeared first on BioTecNika.

Скрыть анонс
16:59 MedicalXpress.com Affordable microscope speeds up malaria diagnosis with AI

Engineers at Stanford University have developed a high-efficiency, battery/solar-operated, autonomous microscope with integrated artificial intelligence that automatically diagnoses malaria in blood smears—a previously tedious process done manually, slide-by-slide, by technicians in the field. The researchers call it Octopi, and believe it could save countless lives through earlier and more accurate diagnosis—and perhaps someday lead to outright eradication of the parasites that cause malaria, the world's deadliest infectious disease. The technology is published on the medRxiv preprint server.

Скрыть анонс
16:34 SciTechDaily.com Physicists Perform “Quantum Surgery” To Fix Errors While Computing

By combining surface codes with lattice surgery, researchers have shown how logical qubits can be manipulated and entangled while remaining protected from errors. Quantum computers are often described as a glimpse of a faster, more powerful future. The catch is that today’s devices are fragile in a way ordinary computers are not. Their biggest headache [...]

Скрыть анонс
14:47 Bioengineer.org AI Stethoscope Identifies Early Signs of Heart Valve Disease, Outpacing Traditional GP Diagnoses, Study Reveals

Artificial intelligence (AI) is making significant strides in various fields, and healthcare is no exception. A recent study led by researchers at the University of Cambridge has unveiled a remarkable application of AI in the early detection of heart valve diseases. This groundbreaking technology has the potential to identify serious conditions like aortic stenosis and […]

Скрыть анонс
14:34 FightAging.org BDNF Gene Therapy Improves Cognitive Function in Alzheimer's Model Mice

The protein BDNF is known to encourage neuroplasticity in the brain and otherwise assist in protecting the health and function of neurons. Numerous studies have demonstrated upregulation of BDNF to improve cognitive function in the context of aging and neurodegenerative conditions. Much of this work focuses on very indirect paths to the upregulation of BDNF, such as manipulation of the gut microbiome, but here researchers take the direct approach of a viral gene therapy introduced into brain tissue via stereotactic injection. They show that this can improve cognitive function in mouse models of Alzheimer's disease Brain-derived neurotrophic factor (BDNF) can protect neurons from apoptosis and maintain normal synaptic structures, indicating a significant potential for Alzheimer's disease (AD) treatment. However, the method of in vivo BDNF […]

Скрыть анонс
13:34 SeekingAlpha.com Regenxbio stock drops on FDA setback for RGX-121 gene therapy

Скрыть анонс
13:09 Optics.org Penn State 4D-prints bio-inspired smart skin for breakthrough in surface engineering

Halftone-encoded printing method uses digital light processing to control hydrogel appearance.

Скрыть анонс
12:26 Arxiv.org CS Learning Potentials for Dynamic Matching and Application to Heart Transplantation

arXiv:2602.08878v1 Announce Type: new Abstract: Each year, thousands of patients in need of heart transplants face life-threatening wait times due to organ scarcity. While allocation policies aim to maximize population-level outcomes, current approaches often fail to account for the dynamic arrival of organs and the composition of waitlisted candidates, thereby hampering efficiency. The United States is transitioning from rigid, rule-based allocation to more flexible data-driven models. In this paper, we propose a novel framework for non-myopic policy optimization in general online matching relying on potentials, a concept originally introduced for kidney exchange. We develop scalable and accurate ways of learning potentials that are higher-dimensional and more expressive than prior approaches. Our approach is a form of self-supervised imitation learning: the potentials are trained to mimic an omniscient algorithm that has perfect foresight. We focus on the application of heart

Скрыть анонс
12:26 Arxiv.org CS Proximal Action Replacement for Behavior Cloning Actor-Critic in Offline Reinforcement Learning

arXiv:2602.07441v1 Announce Type: new Abstract: Offline reinforcement learning (RL) optimizes policies from a previously collected static dataset and is an important branch of RL. A popular and promising approach is to regularize actor-critic methods with behavior cloning (BC), which yields realistic policies and mitigates bias from out-of-distribution actions, but can impose an often-overlooked performance ceiling: when dataset actions are suboptimal, indiscriminate imitation structurally prevents the actor from fully exploiting high-value regions suggested by the critic, especially in later training when imitation is already dominant. We formally analyzed this limitation by investigating convergence properties of BC-regularized actor-critic optimization and verified it on a controlled continuous bandit task. To break this ceiling, we propose proximal action replacement (PAR), a plug-and-play training sample replacer that progressively replaces low-value actions with high-value

Скрыть анонс
12:12 BBC Health Using AI for medical advice 'dangerous', study finds

Oxford researchers find that using AI to make medical decisions presents a risk to patients.

Скрыть анонс
06:47 News-Medical.Net AI model accelerates antibody production and clone selection

As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions.

Скрыть анонс
05:57 News-Medical.Net Medical AI can repeat false claims in clinical contexts

Medical artificial intelligence (AI) is often described as a way to make patient care safer by helping clinicians manage information. A new study by the Icahn School of Medicine at Mount Sinai and collaborators confronts a critical vulnerability: when a medical lie enters the system, can AI pass it on as if it were true?

Скрыть анонс
04:54 Bioengineer.org University of Oklahoma Partners with Industry to Leverage AI for Faster Antibody Drug Development

Monoclonal antibodies stand at the forefront of modern therapeutic interventions, presenting tangible solutions for a myriad of conditions, including certain types of cancers and autoimmune diseases. These engineered proteins mimic the immune system’s ability to fight off pathogens. With an estimated market growth smoothing into a doubling scenario by 2030, the expanding influence of monoclonal […]

Скрыть анонс
02:34 MedicalXpress.com Can medical AI lie? Large study maps how LLMs handle health misinformation

Medical artificial intelligence (AI) is often described as a way to make patient care safer by helping clinicians manage information. A new study by the Icahn School of Medicine at Mount Sinai and collaborators confronts a critical vulnerability: when a medical lie enters the system, can AI pass it on as if it were true?

Скрыть анонс
00:41 MedicalXpress.com AI model can accelerate antibody drug production

As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions. With the market for these therapies forecast to double by 2030, it might seem that the only thing they can't do is grow fast enough. New research from the University of Oklahoma aims to put an end to that limitation, too.

Скрыть анонс
Первая← Предыдущая12345678910Предыдущая →